Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
暂无分享，去创建一个
A. Lockhart | J. Mier | C. Hsueh | D. Quinn | A. Mita | J. Wade | O. Rixe | A. He | J. Sarantopoulos | C. Wack | Jian Y. Yin | J. Morris | P. Clot | J. Hwang | Wenping Zhang | J. Morris | Pierre-François Clot